Identifying and developing products that will improve the health and quality of life of patients remains a primary focus of Forest Laboratories.
05.17.2013 - Forest to Present Aclidinium Bromide and Roflumilast Clinical Data at the American Thoracic Society (ATS) International Conference
05.16.2013 - Forest Laboratories, Inc. to Present Data from Cariprazine and Levomilnacipran Phase 3 Trials at American Psychiatric Association Annual Meeting
05.14.2013 - Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2013
05.09.2013 - Trevena Inc. and Forest Laboratories Announce a Collaborative Agreement for Development of TRV027 for the Treatment of Acute Heart Failure